Biopharma News

Mar 04, 2014
By BioPharm International Editors
Novartis calls for more research to understand and find treatments for rare disease.
Feb 13, 2014
By BioPharm International Editors
Debiopharm acquires Affinium's clinical and preclinical assets and its technology platform.
Jan 31, 2014
By BioPharm International Editors
PharmaCell enters an agreement purchase TiGenix therapy production facility.
Jan 22, 2014
By BioPharm International Editors
J&J's diagnostics business goes to global asset manager, The Carlyle Group.
Jan 22, 2014
By BioPharm International Editors
The Natural Product Center of Excellence seeks to identify novel active compounds for new antibiotics.
Jan 22, 2014
By BioPharm International Editors
Teva announced an agreement to acquire NuPathe and its migraine treatment patch.
Jan 17, 2014
By BioPharm International Editors
CCBR–SYNARC and BioClinica merge to create a provider of specialized outsourced clinical services.
Jan 09, 2014
By BioPharm International Editors
Zymeworks has entered into a licensing and collaboration agreement with ImClone Systems to develop novel bi-specific antibody oncology therapeutics.
Jan 09, 2014
By BioPharm International Editors
Research was published describing a natural interferon-alpha for infection control and treatment of drug-resistant H7N9 influenza.
Jan 09, 2014
By BioPharm International Editors
CytomX Therapeutics and ImmunoGen announce collaboration to develop probody-drug conjugate therapies for the treatment of cancer.
native1_300x100
lorem ipsum